| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |